Heartflow HTFL
NASDAQ HTFL
$50.69 +0.86 (+1.73%)
As of: Sep 30, 2026 · 11:57 AM EDT

Heartflow (HTFL) Current Deferred Revenue (2024 - 2026)

Updated

Heartflow (HTFL) posted Current Deferred Revenue of $861,000 for Q2 2026.

Analysis

Heartflow (HTFL) Current Deferred Revenue (2024 - 2026) Analysis & Trends

At the end of FY2025, Heartflow's Current Deferred Revenue came in at $1.16 million, up 11.6% from FY2024.

  • In prior years, Heartflow's Current Deferred Revenue was $1.04 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn
10 Heartflow 4.33 Bn 4.08 Bn 53.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 861,000.00
Dec 31, 2025 1.16 Mn
Dec 31, 2024 1.04 Mn
API Access

Heartflow Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=HTFL&period=max&api_key=YOUR_API_KEY